Literature DB >> 12731878

Channel formation by the binding component of Clostridium botulinum C2 toxin: glutamate 307 of C2II affects channel properties in vitro and pH-dependent C2I translocation in vivo.

Dagmar Blöcker1, Christoph Bachmeyer, Roland Benz, Klaus Aktories, Holger Barth.   

Abstract

The binding component (C2II) of the binary Clostridium botulinum C2 toxin mediates transport of the actin ADP-ribosylating enzyme component (C2I) into the cytosol of target cells. C2II (80 kDa) is activated by trypsin cleavage, and proteolytically activated C2II (60 kDa) oligomerizes to heptamers in solution. Activated C2II forms channels in lipid bilayer membranes which are highly cation selective and voltage-gated. A role for this channel in C2I translocation across the cell membrane into the cytosol is discussed. Amino acid residues 303-331 of C2II contain a conserved pattern of alternating hydrophobic and hydrophilic residues, which likely facilitates membrane insertion and channel formation by creating two antiparallel beta-strands. Some of the residues are in strategic positions within the putative C2II channel, in particular, glutamate 307 (E307) localized in its center and glycine 316 (G316) localized on the trans side of the membrane. Here, single-lysine substitutions of these amino acids and the double mutant E307K/G316K of C2II were analyzed in vivo and in artificial lipid bilayer experiments. The pH dependence of C2I transport across cellular membranes was altered, and a pH of <or=5.2 was needed for C2I translocation into target cells; otherwise, no change in C2II-promoted entry of C2I into Vero cells was observed. The channel properties of C2II were substantially changed by the mutations, as evidenced by reduced cation selectivity. Interestingly, the voltage dependence of wild-type C2II was completely lost for the E307K mutant, which means that E307 is responsible for voltage gating. Chloroquine blocked the E307K mutant channel and intoxication of Vero cells by mutant C2II and C2I, indicating that chloroquine binding does not involve E307. Overall, the voltage gating and cation selectivity of the C2II channel do not play an important role in translocation of C2I into the cytosol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731878     DOI: 10.1021/bi034199e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

Review 1.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

2.  Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis.

Authors:  Frank Orlik; Bettina Schiffler; Roland Benz
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

Review 3.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

4.  Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.

Authors:  Sergey M Bezrukov; Xian Liu; Vladimir A Karginov; Alexander N Wein; Stephen H Leppla; Michel R Popoff; Holger Barth; Ekaterina M Nestorovich
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

5.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

6.  Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen.

Authors:  Lydia Dmochewitz; Maren Lillich; Eva Kaiser; Laura D Jennings; Alexander E Lang; Johannes Buchner; Gunter Fischer; Klaus Aktories; R John Collier; Holger Barth
Journal:  Cell Microbiol       Date:  2010-11-03       Impact factor: 3.715

Review 7.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

Review 8.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

9.  ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death.

Authors:  Karin Heine; Sascha Pust; Stefanie Enzenmüller; Holger Barth
Journal:  Infect Immun       Date:  2008-08-18       Impact factor: 3.441

10.  Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin.

Authors:  Katharina Ernst; Marc Landenberger; Julian Nieland; Katharina Nørgaard; Manfred Frick; Giorgio Fois; Roland Benz; Holger Barth
Journal:  Toxins (Basel)       Date:  2021-05-28       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.